Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,559,920
+$240,337 QoQ
Shares Held
61,000
-0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#177
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $116,130,341 across 15 Drug Manufacturers - General names. NVS ranks #6 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,147 | $24,164,918 | |
| 2 | JNJ |
Johnson & Johnson
|
77,048 | $19,567,880 | |
| 3 | ABBV |
AbbVie Inc.
|
56,848 | $14,305,230 | |
| 4 | MRK |
Merck & Co., Inc.
|
88,627 | $11,388,569 | |
| 5 | AZN |
Astrazeneca PLC
|
50,534 | $9,582,257 | |
| 6 | NVS |
Novartis AG
This page
|
61,000 | $9,559,920 | |
| 7 | AMGN |
Amgen Inc
|
16,658 | $6,032,194 | |
| 8 | NVO |
Novo Nordisk A S
|
115,512 | $5,537,645 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,559,920 | 61,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,319,583 | 61,012 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $8,252,898 | 59,860 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,655,158 | 59,694 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,949,846 | 57,432 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,243,635 | 64,977 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,761,311 | 18,100 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,041,374 | 17,748 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,848,358 | 17,362 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,623,226 | 16,781 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,702,859 | 16,865 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,502,027 | 14,746 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,424,041 | 14,112 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,310,080 | 14,240 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,006,810 | 11,098 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $795,216 | 10,462 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $759,079 | 8,980 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $890,487 | 10,148 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $621,911 | 7,110 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $673,212 | 8,232 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $729,920 | 8,000 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $657,341 | 7,690 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $677,818 | 7,178 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $621,242 | 7,144 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $688,937 | 7,888 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,112,183 | 25,618 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||